Related Experiment Video
Updated: May 10, 2026
Orthotopic Liver Transplantation in Rats
Published on: July 1, 2012
[Stent-grafts for transjugular intrahepatic portosystemic shunt creation]
I I Zatevakhin1, V N Shipovskiy1,2, M Sh Tsitsiashvili1
1Russian National Research Medical University named after N.I. Pirogov of the of the Ministry of Health of the Russian Federation, 117997, Moscow, Russian Federation.
Objective:
The purpose of this study was to compare clinical results of using an original combined stent construction E-Luminexx + LifeStream and a Hanarostent graft for transjugular intrahepatic portosystemic shunting (TIPS).
Patients And Methods:
We retrospectively analyzed the results of treating a total of 89 patients after a TIPS procedure using either a combined stent construction E-Luminexx + LifeStream or a Hanarostent graft. The study included 44 men and 45 women, average age 54.4±10.1 years (range 33-71). The patients were divided into two groups: Group I consisted of 50 (56.2%) patients subjected to the TIPS procedure using the stent construction E-Luminexx + LifeStream and Group II comprised 39 (43.8%) patients treated with the Hanarostent graft.
Results:
According to Kaplan-Meier analysis, cumulative primary patency in Group I and Group II patients at 1, 6, 24 and 48 months amounted to 93.9%, 91.8%, 81.5% and 73.1 vs 89.7, 81.8, 65,2 and 46.6%, respectively.
Conclusion:
A comparative analysis of the short- and long-term results of TIPS created by means of the combined construction E-Luminexx + LifeStream and the Hanarostent revealed good comparable 12-month primary patency (85.3 vs 76.6%).
More Related Videos
16:19Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
08:39Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
